Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-25 Purchase |
2025-03-27 7:42 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
200,000 | $43.94 | $8,787,921 | 1,202,168 (Indirect Direct) |
View |
| 2025-01-30 Purchase |
2025-02-07 7:54 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
200,000 | $48 | $9,600,000 | 1,002,168 (Indirect Direct) |
View |
| 2024-12-13 Purchase(A) |
2024-12-18 6:52 pm |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) |
View |
| 2024-12-13 Sale(A) |
2024-12-18 6:52 pm |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) |
View |
| 2024-12-17 Purchase |
2024-12-17 7:52 pm |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) |
View |
| 2024-12-17 Sale |
2024-12-17 7:52 pm |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
700,761 | $6.75 | $4,730,137 | 1,408,875 (Indirect) |
View |
| 2024-06-04 Sale(A) |
2024-11-26 4:48 pm |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
1,175,000 | $14.85 | $17,448,750 | 708,114 (Indirect) |
View |
| 2024-06-04 Sale |
2024-06-06 5:01 pm |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
1,175,000 | $14.85 | $17,448,750 | 708,114 (Indirect) |
View |
| 2023-09-12 Purchase |
2023-12-18 6:30 pm |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
640,000 | $10.74 | $6,871,279 | 4,383,875 (Indirect) |
View |
| 2023-12-08 Purchase |
2023-12-11 9:06 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
100,000 | $19.83 | $1,982,940 | 802,168 (Indirect Direct) |
View |
| 2023-11-30 Purchase |
2023-12-05 08:37 am |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
100,000 | $16.95 | $1,694,565 | 702,168 (Indirect Direct) |
View |
| 2023-08-08 Purchase |
2023-08-10 4:46 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
25,000 | $42.06 | $1,051,475 | 602,168 (Indirect Direct) |
View |
| 2023-07-28 Purchase |
2023-08-01 7:52 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
55,000 | $42.95 | $2,362,234 | 577,168 (Indirect Direct) |
View |
| 2022-09-19 Purchase(A) |
2023-06-15 9:26 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
520,000 | $29.69 | $15,440,000 | 522,168 (Indirect Direct) |
View |
| 2023-05-19 Purchase |
2023-05-23 9:55 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
520,000 | $29.69 | $15,440,000 | 522,168 (Indirect Direct) |
View |
| 2020-12-14 Purchase |
2020-12-15 7:07 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director |
20,000 | $76 | $1,520,000 | 3,156,981 (Indirect) |
View |
| 2020-11-23 Purchase |
2020-11-23 4:35 pm |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
1,160,000 | $19 | $22,040,000 | 1,160,000 (Indirect) |
View |
| 2020-07-21 Purchase |
2020-07-21 8:04 pm |
ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director |
975,000 | $19 | $18,525,000 | 975,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-14 Option Award |
2024-06-18 5:00 pm |
N/A 2034-06-14 |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
23,000 | $0 | 23,000 (Direct) |
View |
| 2024-06-08 Option Award |
2024-06-11 5:29 pm |
N/A 2034-06-07 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
26,000 | $0 | 26,000 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:48 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-17 Option Award(A) |
2022-06-27 5:10 pm |
N/A 2032-06-16 |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-17 7:25 pm |
N/A 2032-06-15 |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-03 4:06 pm |
N/A 2032-06-01 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-11 Option Award |
2021-06-15 7:03 pm |
N/A 2031-06-10 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director |
12,004 | $0 | 12,004 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-10 6:38 pm |
N/A 2031-06-08 |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
21,520 | $0 | 21,520 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:55 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
13,000 | $0 | 62,832 (Direct) |
View |
| 2021-06-01 Gift |
2021-06-03 5:55 pm |
N/A 2031-05-31 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
49,832 | $0 | 62,832 (Direct) |
View |
| 2020-11-23 Conversion |
2020-11-23 4:35 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
2,583,875 | $0 | 1,160,000 (Indirect) |
View |
Ownership |
2020-11-20 7:06 pm |
N/A N/A |
Lifesci Acquisition II Corp. | LSAQ | Graham G. Walmsley Director |
0 | $0 | 6,000 (Direct) |
View |
| 2020-11-18 Option Award |
2020-11-19 7:01 pm |
N/A 2030-11-17 |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
64,560 | $0 | 1,587,252 (Direct) |
View |
Ownership |
2020-11-18 6:41 pm |
N/A N/A |
Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director |
0 | $0 | 2,583,875 (Indirect) |
View |
| 2020-07-21 Conversion |
2020-07-21 8:04 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director |
2,105,901 | $0 | 975,000 (Indirect) |
View |
| 2020-07-16 Option Award |
2020-07-17 7:10 pm |
N/A 2030-07-16 |
ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director |
24,009 | $0 | 24,009 (Direct) |
View |
Ownership |
2020-07-16 6:41 pm |
N/A N/A |
ALX ONCOLOGY HOLDINGS INC | ALXO | Graham G. Walmsley Director |
0 | $0 | 2,105,901 (Indirect) |
View |
| 2020-06-01 Option Award |
2020-06-02 6:53 pm |
N/A 2030-05-31 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
13,000 | $0 | 13,000 (Direct) |
View |